Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)
Jennifer H. Foster, Joel M. Reid, Charles G. Minard, Sarah E. Woodfield, Kristina Z. Denic, Emasenyie Isikwei, Stephan D. Voss, Marvin D. Nelson, Xiaowei Liu, Stacey L. Berg, Elizabeth Fox, Brenda J. Weigel
Topics & Concepts
Refractory (planetary science)ChemotherapyMedicineSolid tumorCancer researchPhase (matter)OncologyInternal medicineMaterials scienceChemistryCancerMetallurgyOrganic chemistryUbiquitin and proteasome pathwaysATP Synthase and ATPases ResearchCancer-related Molecular Pathways